{
    "data": [
        {
            "id": "69a058f824c37e0001bb5718",
            "title": "Here&#39;s How Much You Would Have Made Owning Teledyne Technologies Stock In The Last 10 Years",
            "description": "<div><div class=\"sc-gfrmXj kPLDLR\"><!--$--><p class=\"block core-block\">Teledyne Technologies (NYSE:<a class=\"ticker\" href=\"https://www.benzinga.com/quote/TDY\" target=\"_blank\">TDY</a>) has outperformed the market over the past 10 years by 9.43% on an annualized basis producing an average annual return of 22.72%. Currently, Teledyne Technologies has a market capitalization of $31.37 billion. </p><!--/$--><!--$--><p class=\"block core-block\"><strong>Buying $100 In TDY:</strong> If an investor had bought $100 of TDY stock 10 years ago, it would be worth <strong>$784.37</strong> today based on a price of $677.38 for TDY at the time of writing.</p><!--/$--><!--$--><h3 class=\"block core-block\">Teledyne Technologies's Performance Over Last 10 Years</h3><!--/$--><!--$?--><template id=\"B:1\"></template><div></div><!--/$--><!--$--><p class=\"block core-block\">Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.</p><!--/$--><!--$--><p class=\"block core-block\"><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p><!--/$--><!--$--><div class=\"sc-jHrKIi gTZsSs\"></div><!--/$--></div></div>",
            "image": "",
            "link": "https://www.benzinga.com/insights/news/26/02/50888946/heres-how-much-you-would-have-made-owning-teledyne-technologies-stock-in-the-last-10-years",
            "pub_date": "2026-02-26 22:30:21",
            "source": "benzinga",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "69a05a1124c37e0001bb57ba",
            "title": "Marco Rubio Says Iran Has Weapons &#39;Solely Designed To Attack America,&#39; But What Do Prediction Markets Say?",
            "description": "<div><div class=\"sc-gfrmXj kPLDLR\"><!--$--><p class=\"block core-block\">Secretary of State <strong>Marco Rubio</strong> said Wednesday that Iran possesses conventional weapons “solely designed to attack America and attack Americans if they so choose to do so.”</p><!--/$--><!--$--><p class=\"block core-block\">He warned Tehran is pursuing intercontinental ballistic missiles and called its refusal to discuss the missile program a “big <a href=\"https://www.state.gov/releases/office-of-the-spokesperson/2026/02/secretary-of-state-marco-rubio-remarks-to-press-5\" target=\"_blank\">problem</a>.”</p><!--/$--><!--$--><div class=\"min-w-[300px] w-[300px] min-h-[250px] raptive-ad-placement mx-auto overflow-hidden min-w-[300px]\"></div><!--/$--><!--$--><p class=\"block core-block\">Vice President <strong>JD Vance</strong> went further: “You can’t let the craziest and worst regime in the world have nuclear <a href=\"https://www.pbs.org/newshour/amp/world/iran-accuses-trump-of-big-lies-in-the-face-of-major-u-s-military-buildup-and-upcoming-talks\" target=\"_blank\">weapons</a>.”</p><!--/$--><!--$--><h2 class=\"wp-block-heading\">Response from Tehran</h2><!--/$--><!--$--><p class=\"block core-block\">Iran’s foreign ministry spokesman <strong>Esmaeil Baghaei</strong> spoke on Monday with language that left zero room for interpretation: “An act of aggression would be regarded as an act of aggression. Period. Any state would react <a href=\"https://www.benzinga.com/markets/prediction-markets/26/02/50784859/trump-sets-deal-deadline-as-iran-threatens-ferocious-retaliation-what-do-prediction-markets-say\" target=\"_blank\">ferociously</a>.”</p><!--/$--><!--$--><div class=\"sc-jHrKIi gTZsSs\"></div><!--/$--><!--$--><p class=\"block core-block\">Yet on Tuesday, Foreign Minister <strong>Abbas Araghchi</strong> struck a different tone, saying a deal was “within reach” if “diplomacy is given <a href=\"https://x.com/araghchi/status/2026353054480486666?s=20\" target=\"_blank\">priority</a>.” </p><!--/$--><!--$--><p class=\"block core-block\">The mixed messaging captures the bind Tehran is in: threatening retaliation while signaling it would rather negotiate.</p><!--/$--><!--$--><p class=\"block core-block\">A third round of talks opened Thursday in Geneva. </p><!--/$--><!--$--><div class=\"min-w-[300px] w-[300px] min-h-[250px] raptive-ad-placement mx-auto overflow-hidden min-w-[300px]\"></div><!--/$--><!--$--><h2 class=\"wp-block-heading\">What Are Prediction Markets Saying?</h2><!--/$--><!--$--><p class=\"block core-block\"><strong>Polymarket’s </strong><a href=\"https://polymarket.com/event/us-strikes-iran-by\" target=\"_blank\">“US strikes Iran by…?”</a> market has now crossed $430 million in total volume, making it one of the largest current markets on Polymarket.</p><!--/$--><!--$--><p class=\"block core-block\">Near-term odds remain moderate: 10% by end of February.</p><!--/$--><!--$--><p class=\"block core-block\">But by March 31, the odds of a strike have moved from 30% to 55% in a week, as the talks have not led to a cooling of tempers. </p><!--/$--><!--$--><p class=\"block core-block\">The odds of a strike this year have held roughly steady, at 70%.</p><!--/$--><!--$--><p class=\"block core-block\">On the diplomacy side, a <a href=\"https://polymarket.com/event/us-iran-nuclear-deal-by-march-31\" target=\"_blank\">US-Iran nuclear deal by March 31</a> is priced at just 30%. A deal before 2027 is a coin flip at 50%.</p><!--/$--><!--$--><p class=\"block core-block\">A separate contract pricing an <a href=\"https://polymarket.com/event/iran-strike-on-us-military-by-march-31\" target=\"_blank\">Iranian strike on U.S. military assets by March 31</a> sits at 30%.</p><!--/$--><!--$--><div class=\"min-w-[300px] w-[300px] min-h-[250px] raptive-ad-placement mx-auto overflow-hidden min-w-[300px]\"></div><!--/$--><!--$--><h2 class=\"wp-block-heading\">Stocks To Watch</h2><!--/$--><!--$?--><template id=\"B:2\"></template><div></div><!--/$--><!--$--><p class=\"block core-block\">Boeing built the 30,000-pound bunker-buster bombs that collapsed the Fordow enrichment facility, while RTX’s Tomahawk cruise missiles hit Isfahan.</p><!--/$--><!--$--><p class=\"block core-block\">A renewed military campaign would likely mean fresh orders for both. </p><!--/$--><!--$--><p class=\"block core-block\">RTX carries a $251 billion <a href=\"https://www.benzinga.com/markets/earnings/25/10/48326393/rtx-lifts-2025-outloohttps://www.benzinga.com/markets/earnings/25/10/48326393/rtx-lifts-2025-outlook-as-ceo-highlights-strong-growthk-as-ceo-highlights-strong-growth\" target=\"_blank\">backlog </a>and its stock has gained over 38% in the past year.</p><!--/$--><!--$--><div class=\"nativo-placement-in-content-ap\"></div><!--/$--><!--$--><p class=\"block core-block\"><strong>Palantir Technologies</strong> <a class=\"ticker-link\" data-exchange=\"NASDAQ\" data-ticker=\"PLTR\" href=\"https://www.benzinga.com/quote/PLTR\" rel=\"noopener\" target=\"_blank\">(NASDAQ:</a><a class=\"ticker\" href=\"https://www.benzinga.com/quote/PLTR\" target=\"_blank\">PLTR</a>)<!-- -->, whose Pentagon analytics platforms underpin U.S. targeting and intelligence operations in the Gulf, tends to catch a bid every time the military footprint expands.</p><!--/$--><!--$--><p class=\"block core-block\">Iran sits astride the <a href=\"https://www.benzinga.com/markets/prediction-markets/26/02/50668917/trump-called-iran-tough-negotiators-what-do-prediction-markets-say-about-a-nuclear-deal\" target=\"_blank\">Strait of Hormuz</a>, the chokepoint through which 13 million barrels per day of crude transit. </p><!--/$--><!--$--><p class=\"block core-block\">Brent crude recently hit a six-month high near $71.70, with Goldman Sachs estimating a $6-per-barrel geopolitical risk premium already baked in. </p><!--/$--><!--$--><p class=\"block core-block\">Polymarket prices a 35% chance Iran <a href=\"https://polymarket.com/event/will-iran-close-the-strait-of-hormuz-by-2027\" target=\"_blank\">closes </a>the strait by year-end.</p><!--/$--><!--$?--><template id=\"B:3\"></template><div></div><!--/$--><!--$--><p class=\"block core-block\"><em>Image: Shutterstock</em></p><!--/$--><!--$--><div class=\"bz-optimizely-campaign bz-optimizely-campaign-bottom-50889083\" data-nosnippet=\"true\"></div><!--/$--></div></div>",
            "image": "https://www.benzinga.com/files/images/story/2026/02/26/Iran-Insists-It-Wont-Build-Nukes.jpeg",
            "link": "https://www.benzinga.com/markets/prediction-markets/26/02/50889083/marco-rubio-says-iran-has-weapons-solely-designed-to-attack-america-but-what-do-prediction-markets-say",
            "pub_date": "2026-02-26 22:35:00",
            "source": "benzinga",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "69a0566424c37e0001bb552e",
            "title": "Celsius Stock Surges 10% After Q4 Double Beat",
            "description": "<div><div class=\"sc-gfrmXj kPLDLR\"><!--$--><p class=\"block core-block\"><strong>Celsius Holdings, Inc.</strong> <a class=\"ticker-link\" data-exchange=\"NASDAQ\" data-ticker=\"CELH\" href=\"https://www.benzinga.com/quote/CELH\" rel=\"noopener\" target=\"_blank\">(NASDAQ:</a><a class=\"ticker\" href=\"https://www.benzinga.com/quote/CELH\" target=\"_blank\">CELH</a>)<!-- --> shares are trading higher Thursday after the company reported fourth-<a href=\"https://www.benzinga.com/node/50879177\" target=\"_blank\">quarter financial results</a>.</p><!--/$--><!--$--><ul class=\"wp-block-list\">\n<li>Celsius Holdings stock is showing exceptional strength. <a href=\"https://www.benzinga.com/quote/CELH\" rel=\"noreferrer noopener\" target=\"_blank\">What’s fueling CELH momentum?</a></li>\n</ul><!--/$--><!--$--><div class=\"min-w-[300px] w-[300px] min-h-[250px] raptive-ad-placement mx-auto overflow-hidden min-w-[300px]\"></div><!--/$--><!--$--><h2 class=\"wp-block-heading\"><strong>Double Beat Fueled By Alani Nu, Rockstar Contributions</strong></h2><!--/$--><!--$--><p class=\"block core-block\">The company reported adjusted earnings per share of 26 cents, beating the consensus estimate of 20 cents. In addition, Celsius reported revenue of $721.62 million, beating the consensus estimate of $640.83 million and marking a 117% increase from $332.2 million in the prior-year quarter.</p><!--/$--><!--$--><p class=\"block core-block\">The revenue increase reflected the acquisitions of Alani Nu on April 1 and Rockstar Energy on Aug. 28. Alani Nu generated record fourth-quarter sales of approximately $370 million, benefiting from strong customer demand and increased orders tied to its transition into the PepsiCo distribution system. Rockstar Energy contributed approximately $45 million in revenue during the quarter.</p><!--/$--><!--$--><div class=\"sc-jHrKIi gTZsSs\"></div><!--/$--><!--$?--><template id=\"B:2\"></template><div></div><!--/$--><!--$--><p class=\"block core-block\">International revenue rose 9% year-over-year to $22.1 million, driven by growth in the Nordics and continued expansion in markets including the UK, Ireland, France, Australia, New Zealand and Benelux.</p><!--/$--><!--$--><p class=\"block core-block\">Chairman and CEO <strong>John Fieldly</strong> said, \"With CELSIUS, Alani Nu, and Rockstar Energy, we’re building a scaled Modern Energy portfolio with distinct roles, recruiting new consumers and expanding consumption occasions.\"</p><!--/$--><!--$--><div class=\"min-w-[300px] w-[300px] min-h-[250px] raptive-ad-placement mx-auto overflow-hidden min-w-[300px]\"></div><!--/$--><!--$--><h2 class=\"wp-block-heading\">Celsius Shares Climb Higher</h2><!--/$--><!--$--><p class=\"block core-block\">CELH Price Action: At the time of writing, Celsius shares are trading 18.26% higher at $59.85, according to data from <a href=\"https://pro.benzinga.com/dashboard\" target=\"_blank\">Benzinga Pro</a>.</p><!--/$--><!--$--><p class=\"block core-block\"><em>Image via Shutterstock</em></p><!--/$--><!--$--><div class=\"bz-optimizely-campaign bz-optimizely-campaign-bottom-50888473\" data-nosnippet=\"true\"></div><!--/$--></div></div>",
            "image": "https://www.benzinga.com/files/images/story/2026/02/26/Miami-Beach--Florida---July-02--2024-Cel.jpeg",
            "link": "https://www.benzinga.com/trading-ideas/movers/26/02/50888473/celsius-stock-surges-10-after-q4-double-beat",
            "pub_date": "2026-02-26 22:19:19",
            "source": "benzinga",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "69a056f724c37e0001bb556b",
            "title": "C3.Ai Stock Sinks After Q3 Miss, Fiscal 2026 Forecast Cut Nearly In Half",
            "description": "<div><div class=\"sc-gfrmXj kPLDLR\"><!--$--><p class=\"block core-block\"><strong>C3.Ai, Inc.</strong> <a class=\"ticker-link\" data-exchange=\"NYSE\" data-ticker=\"AI\" href=\"https://www.benzinga.com/quote/AI\" rel=\"noopener\" target=\"_blank\">(NYSE:</a><a class=\"ticker\" href=\"https://www.benzinga.com/quote/AI\" target=\"_blank\">AI</a>)<!-- --> shares are trading lower Thursday after the company reported worse-than-expected third-<a href=\"https://www.benzinga.com/node/50874367\" target=\"_blank\">quarter financial results.</a> </p><!--/$--><!--$--><ul class=\"wp-block-list\">\n<li>C3.Ai stock is testing lower boundaries. <a href=\"https://www.benzinga.com/quote/AI\" rel=\"noreferrer noopener\" target=\"_blank\">What’s behind AI weakness?</a></li>\n</ul><!--/$--><!--$--><div class=\"min-w-[300px] w-[300px] min-h-[250px] raptive-ad-placement mx-auto overflow-hidden min-w-[300px]\"></div><!--/$--><!--$--><h2 class=\"wp-block-heading\">Wide Miss, Lower Outlook Drive Post-Earnings Selloff</h2><!--/$--><!--$--><p class=\"block core-block\">The company reported an adjusted loss of 40 cents per share, wider than the consensus estimate for a 29-cent loss. Revenue totaled $53.26 million, missing the Street estimate of $75.61 million by more than 29% and declining from $98.78 million in the same period last year.</p><!--/$--><!--$--><p class=\"block core-block\">C3.ai also announced a restructuring plan and workforce reductions.</p><!--/$--><!--$--><div class=\"sc-jHrKIi gTZsSs\"></div><!--/$--><!--$--><p class=\"block core-block\">\"I joined C3 AI six months ago and I did so with a clear conviction: this company is uniquely positioned to win in Enterprise AI. That conviction has been reinforced through extensive engagement with customers, prospects, partners and investors,\" said CEO <strong>Stephen Ehikian</strong>. \"However, it was clear to me that we were not organized appropriately.\"</p><!--/$--><!--$--><p class=\"block core-block\">Looking ahead, the company forecast fourth-quarter revenue of $48 million to $52 million, below the consensus estimate of $77.69 million.</p><!--/$--><!--$--><p class=\"block core-block\">C3.ai also slashed its fiscal 2026 revenue guidance from a prior range of $447.5 million to $484.5 million to a new range of $246.7 million to $250.7 million.</p><!--/$--><!--$--><div class=\"min-w-[300px] w-[300px] min-h-[250px] raptive-ad-placement mx-auto overflow-hidden min-w-[300px]\"></div><!--/$--><!--$--><h2 class=\"wp-block-heading\">C3.Ai Stock Plummets Lower</h2><!--/$--><!--$--><p class=\"block core-block\"><strong>AI Price Action:</strong> At the time of writing, C3.Ai shares are trading 24.45% lower at $7.780, according to data from <a href=\"https://pro.benzinga.com/dashboard\" target=\"_blank\">Benzinga Pro</a>.</p><!--/$--><!--$--><p class=\"block core-block\"><em>Image via Shutterstock</em></p><!--/$--><!--$--><div class=\"bz-optimizely-campaign bz-optimizely-campaign-bottom-50888528\" data-nosnippet=\"true\"></div><!--/$--></div></div>",
            "image": "https://www.benzinga.com/files/images/story/2026/02/26/Jakarta---September-17-2023-C3-ai-also-C.jpeg",
            "link": "https://www.benzinga.com/trading-ideas/movers/26/02/50888528/c3-ai-stock-sinks-after-q3-miss-fiscal-2026-forecast-cut-nearly-in-half",
            "pub_date": "2026-02-26 22:21:47",
            "source": "benzinga",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "69a0552c24c37e0001bb5439",
            "title": "Fate Therapeutics Q4 Earnings Summary &amp; Key Takeaways",
            "description": "<div><div class=\"sc-gfrmXj kPLDLR\"><!--$--><p class=\"block core-block\"><strong>Fate Therapeutics</strong> (NASDAQ:<a class=\"ticker\" href=\"https://www.benzinga.com/quote/FATE\" target=\"_blank\">FATE</a>) released its Q4 earnings on Thursday, February 26, 2026 at 09:00 AM.</p><!--/$--><!--$--><p class=\"block core-block\">Here's what's important from the earnings announcement.</p><!--/$--><!--$--><h3 class=\"block core-block\">Earnings</h3><!--/$--><!--$--><p class=\"block core-block\">Fate Therapeutics missed estimated earnings by 0.0%, reporting an EPS of $-0.27 versus an estimate of $-0.27.</p><!--/$--><!--$--><p class=\"block core-block\">Revenue was down $491 thousand from the same period last year.</p><!--/$--><!--$--><h3 class=\"block core-block\">Analysis of Past Earnings</h3><!--/$--><!--$--><p class=\"block core-block\">The company beat on EPS by $0.01 in the last quarter, resulting in a 2.85% drop share price change the following day.</p><!--/$--><!--$--><p class=\"block core-block\">Here's a look at Fate Therapeutics's past performance:</p><!--/$--><!--$--><!--/$--><!--$--><p class=\"block core-block\">To track all earnings releases for Fate Therapeutics <a href=\"https://www.benzinga.com/quote/FATE/earnings\" target=\"_blank\">visit their earnings calendar here.</a> </p><!--/$--><!--$--><p class=\"block core-block\">This article was generated by Benzinga's automated content engine and reviewed by an editor.</p><!--/$--></div></div>",
            "image": "https://www.benzinga.com/files/images/story/2025/11/06/analyst_ratings_3.jpg",
            "link": "https://www.benzinga.com/insights/earnings/26/02/50888263/fate-therapeutics-q4-earnings-summary-key-takeaways",
            "pub_date": "2026-02-26 22:14:08",
            "source": "benzinga",
            "kind": 1,
            "language": "en"
        }
    ]
}